✨ Unlock Data Exports And Disclosure Access.Start Your 30-Day Free Trial Today →

Innovent Biologics Inc

Common Name
Innovent Biologics
Country
China (Mainland)
Sector
Healthcare
Industry
Biotechnology
Employees
5,659
Ticker
1801
Exchange
Hong Kong Exchanges and Clearing Limited
Description
Innovent Biologics Inc. engages in the research, development, manufacture, and sale of biologic therapies, primarily focusing on oncology, autoimmune, metabolic, and other major diseases. As a pharmac...

Innovent Biologics's Board Composition Data

Explore Innovent Biologics's board composition data, including the total number of board members and their breakdown by executive/non-executive status, independence, and gender.

Metric2026/4/22
Total Board Members
9a
Executive Board Members
3a
Non-Executive Board Members
6a
Independent Board Members
6a
Non-Independent Board Members
3a
Female Board Members
2a
Male Board Members
7a
Non-Binary Board Members
0a
Usage Policy

You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"

Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.

Verified Sources Behind Innovent Biologics’s Board Composition Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.

a. Innovent Biologics's Annual Report 2025